FINOSE now covers all Nordic countries

18 April 2024 - Icelandic Landspitali joins the Nordic collaboration FINOSE, where HTA authorities from the Nordic countries carry out ...

Read more →

DoH published revised agenda for July 2024 PBAC meeting (12 April 2024)

12 April 2024 - Version 2 of the agenda for the July 2024 PBAC meeting is now available; two minor ...

Read more →

Updates to the HTA Policy and Methods Review Reference Committee (15 April 2024)

15 April 2024 - The HTA Review Reference Committee is finalising its report and recommendations to the Australian Government having ...

Read more →

HTA review - is today D day?

15 April 2024 - The review is due to be completed by 15 April 2024 (today). ...

Read more →

NICE issues final draft guidance for use of remdesivir and also for tixagevimab-cilgavimab (Evusheld) for treatment of COVID-19

9 April 2024 - Final draft guidance for remdesivir and for tixagevimab with cilgavimab has been published by NICE. ...

Read more →

170,000 people in England to have further treatment choice for preventing migraine attacks

11 April 2024 - In final draft guidance published today NICE has recommended atogepant, the first of a new type of ...

Read more →

Children and young adults to benefit after NICE recommends personalised immunotherapy to treat blood cancer be made routinely available on the NHS

11 April 2024 - Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia. ...

Read more →

ICER releases draft evidence report on treatment for chronic obstructive pulmonary disease

10 April 2024 - Public comment period now open until 7 May 2024; requests to make oral comment during public ...

Read more →

Cabozantinib maleate in combination with nivolumab for the first-line treatment of patients with advanced renal cell carcinoma

10 April 2024 - NICE has published final evidence-based recommendations on the use of cabozantinib maleate (Cabometyx) in combination with ...

Read more →

SMC - April 2024 decisions

8 April 2024 - The SMC has today published advice on seven medicines. ...

Read more →

Public summary documents – December 2023 PBAC meeting

5 April 2024 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the December 2023 PBAC ...

Read more →

New model validation tool to support economic evaluations of health technologies

1 April 2024 - CADTH has developed a comprehensive and accessible tool to support the validation of economic models used in ...

Read more →

Agenda for the July 2024 PBAC meeting

3 April 2024 - The agenda for the July 2024 PBAC meeting is now available. ...

Read more →

Dostarlimab in combination with platinum-based chemotherapy for the treatment of patients with advanced or recurrent, high microsatellite instability or mismatch repair deficiency endometrial cancer

3 April 2024 - NICE has published final evidence-based recommendations on the use of dostarlimab (Jemperli) in combination with platinum-based ...

Read more →

MSAC publishes agenda for 1-2 August 2024 MSAC meeting

3 April 2024 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC ...

Read more →